...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trading

I'm not surprised they don't like it.  Must be pretty tough to do a financing at $1.00 when it's trading at 0.07.  But maybe it's an incentive to sell the company. 

Amazing, the motivated seller who just blew through the buy orders at 15 cents, 10 cents, and at 7 cents where it is now. 

Congrats to whoever is picking it up at 7 cents.  It ain't me.

 

Share
New Message
Please login to post a reply